Meta Pharmacy Recalls Compounded Eye Drops Due to Sterility Concerns
Meta Pharmacy Services is recalling Phenylephrine and Tropicamide compounded eye drops due to a lack of sterility assurance. The affected product was distributed to one consignee in Las Vegas.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a sterile compounded drug (where lack of sterility assurance implies a risk of serious injury or hospitalization) corresponds to a severity score of 4 (Severe).
Plain-English summary
Meta Pharmacy Services is recalling Phenylephrine 2.5% + Tropicamide 1% Compounded Eye Drops Solution, 5 mL bottles, due to a lack of sterility assurance. The recalled product is identified by Lot 112716SB and has an expiration date of 12/27/2016. The NDC number is 99999-0106-99.
The product is a sterile compounded drug intended for hospital or office use only and is not for resale. It is stored at room temperature. The recall involves a total quantity of 150 mL.
The affected product was distributed to one consignee in Las Vegas. Because the product is for professional medical use, consumers are unlikely to have this product in their homes. Healthcare facilities and pharmacies should stop using the product and contact the recalling firm for instructions on return or disposal.
The recalled product
- Product
- Phenylephrine 2.5% + Tropicamide 1% Compounded Eye Drops Solution, 5 mL bottles, Meta Pharmacy Services. NDC 99999-0106-99 Sterile compounded drug, Hospital/office use only, Not for resale Storage: ROOM TEMP
- Manufacturer
- Meta Pharmacy Services
- Category
- Drug — Compounded Sterile Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 112716SB
- Exp. 12/27/2016
Distribution
Distribution scope not specified by the agency.
Related recalls
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15